Kintara Therapeutics, Inc. announced that as a result of cost-cutting measures adopted by the company on November 20, 2023, Dennis Brown was terminated from his position as the Company's Chief Scientific Officer, effective immediately. Dr. Brown will continue as a consultant to the Company, in which Dr. Brown will provide advisory services to the Company on a part-time, month-to-month basis for a fee of no more than $350 per hour.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1488 USD | -5.82% | +22.57% | -12.26% |
Apr. 03 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Apr. 03 | Sector Update: Health Care | MT |
1st Jan change | Capi. | |
---|---|---|
-12.26% | 8.23M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KTRA Stock
- News Kintara Therapeutics, Inc.
- Kintara Therapeutics, Inc. Announces Executive Changes